Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-01-01 @ 10:10 PM
Study NCT ID:
NCT07170293
Status:
RECRUITING
Last Update Posted:
2025-09-12
First Post:
2025-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
Sponsor:
Organization: